Paediatrics (RCH) - Research Publications

Permanent URI for this collection

Search Results

Now showing 1 - 7 of 7
  • Item
    Thumbnail Image
    Acromelic frontonasal dysostosis and ZSWIM6 mutation: phenotypic spectrum and mosaicism.
    Twigg, SRF ; Ousager, LB ; Miller, KA ; Zhou, Y ; Elalaoui, SC ; Sefiani, A ; Bak, GS ; Hove, H ; Hansen, LK ; Fagerberg, CR ; Tajir, M ; Wilkie, AOM (Wiley, 2016-09)
    Acromelic frontonasal dysostosis (AFND) is a distinctive and rare frontonasal malformation that presents in combination with brain and limb abnormalities. A single recurrent heterozygous missense substitution in ZSWIM6, encoding a protein of unknown function, was previously shown to underlie this disorder in four unrelated cases. Here we describe four additional individuals from three families, comprising two sporadic subjects (one of whom had no limb malformation) and a mildly affected female with a severely affected son. In the latter family we demonstrate parental mosaicism through deep sequencing of DNA isolated from a variety of tissues, which each contain different levels of mutation. This has important implications for genetic counselling.
  • Item
    Thumbnail Image
    Biallelic GINS2 variant p.(Arg114Leu) causes Meier-Gorlin syndrome with craniosynostosis.
    Nabais Sá, MJ ; Miller, KA ; McQuaid, M ; Koelling, N ; Wilkie, AOM ; Wurtele, H ; de Brouwer, APM ; Oliveira, J (BMJ, 2022-08)
    INTRODUCTION: Replication of the nuclear genome is an essential step for cell division. Pathogenic variants in genes coding for highly conserved components of the DNA replication machinery cause Meier-Gorlin syndrome (MGORS). OBJECTIVE: Identification of novel genes associated with MGORS. METHODS: Exome sequencing was performed to investigate the genotype of an individual presenting with prenatal and postnatal growth restriction, a craniofacial gestalt of MGORS and coronal craniosynostosis. The analysis of the candidate variants employed bioinformatic tools, in silico structural protein analysis and modelling in budding yeast. RESULTS: A novel homozygous missense variant NM_016095.2:c.341G>T, p.(Arg114Leu), in GINS2 was identified. Both non-consanguineous healthy parents carried this variant. Bioinformatic analysis supports its classification as pathogenic. Functional analyses using yeast showed that this variant increases sensitivity to nicotinamide, a compound that interferes with DNA replication processes. The phylogenetically highly conserved residue p.Arg114 localises at the docking site of CDC45 and MCM5 at GINS2. Moreover, the missense change possibly disrupts the effective interaction between the GINS complex and CDC45, which is necessary for the CMG helicase complex (Cdc45/MCM2-7/GINS) to accurately operate. Interestingly, our patient's phenotype is strikingly similar to the phenotype of patients with CDC45-related MGORS, particularly those with craniosynostosis, mild short stature and patellar hypoplasia. CONCLUSION: GINS2 is a new disease-associated gene, expanding the genetic aetiology of MGORS.
  • Item
    Thumbnail Image
    Genome-Wide ENU Mutagenesis in Combination with High Density SNP Analysis and Exome Sequencing Provides Rapid Identification of Novel Mouse Models of Developmental Disease
    Caruana, G ; Farlie, PG ; Hart, AH ; Bagheri-Fam, S ; Wallace, MJ ; Dobbie, MS ; Gordon, CT ; Miller, KA ; Whittle, B ; Abud, HE ; Arkell, RM ; Cole, TJ ; Harley, VR ; Smyth, IM ; Bertram, JF ; Veitia, RA (PUBLIC LIBRARY SCIENCE, 2013-03-01)
    BACKGROUND: Mice harbouring gene mutations that cause phenotypic abnormalities during organogenesis are invaluable tools for linking gene function to normal development and human disorders. To generate mouse models harbouring novel alleles that are involved in organogenesis we conducted a phenotype-driven, genome-wide mutagenesis screen in mice using the mutagen N-ethyl-N-nitrosourea (ENU). METHODOLOGY/PRINCIPAL FINDINGS: ENU was injected into male C57BL/6 mice and the mutations transmitted through the germ-line. ENU-induced mutations were bred to homozygosity and G3 embryos screened at embryonic day (E) 13.5 and E18.5 for abnormalities in limb and craniofacial structures, skin, blood, vasculature, lungs, gut, kidneys, ureters and gonads. From 52 pedigrees screened 15 were detected with anomalies in one or more of the structures/organs screened. Using single nucleotide polymorphism (SNP)-based linkage analysis in conjunction with candidate gene or next-generation sequencing (NGS) we identified novel recessive alleles for Fras1, Ift140 and Lig1. CONCLUSIONS/SIGNIFICANCE: In this study we have generated mouse models in which the anomalies closely mimic those seen in human disorders. The association between novel mutant alleles and phenotypes will lead to a better understanding of gene function in normal development and establish how their dysfunction causes human anomalies and disease.
  • Item
    Thumbnail Image
    A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis.
    Schwerd, T ; Twigg, SRF ; Aschenbrenner, D ; Manrique, S ; Miller, KA ; Taylor, IB ; Capitani, M ; McGowan, SJ ; Sweeney, E ; Weber, A ; Chen, L ; Bowness, P ; Riordan, A ; Cant, A ; Freeman, AF ; Milner, JD ; Holland, SM ; Frede, N ; Müller, M ; Schmidt-Arras, D ; Grimbacher, B ; Wall, SA ; Jones, EY ; Wilkie, AOM ; Uhlig, HH (Rockefeller University Press, 2017-09-04)
    Multiple cytokines, including interleukin 6 (IL-6), IL-11, IL-27, oncostatin M (OSM), and leukemia inhibitory factor (LIF), signal via the common GP130 cytokine receptor subunit. In this study, we describe a patient with a homozygous mutation of IL6ST (encoding GP130 p.N404Y) who presented with recurrent infections, eczema, bronchiectasis, high IgE, eosinophilia, defective B cell memory, and an impaired acute-phase response, as well as skeletal abnormalities including craniosynostosis. The p.N404Y missense substitution is associated with loss of IL-6, IL-11, IL-27, and OSM signaling but a largely intact LIF response. This study identifies a novel immunodeficiency with phenotypic similarities to STAT3 hyper-IgE syndrome caused by loss of function of GP130.
  • Item
    Thumbnail Image
    Diagnostic value of exome and whole genome sequencing in craniosynostosis.
    Miller, KA ; Twigg, SRF ; McGowan, SJ ; Phipps, JM ; Fenwick, AL ; Johnson, D ; Wall, SA ; Noons, P ; Rees, KEM ; Tidey, EA ; Craft, J ; Taylor, J ; Taylor, JC ; Goos, JAC ; Swagemakers, SMA ; Mathijssen, IMJ ; van der Spek, PJ ; Lord, H ; Lester, T ; Abid, N ; Cilliers, D ; Hurst, JA ; Morton, JEV ; Sweeney, E ; Weber, A ; Wilson, LC ; Wilkie, AOM (BMJ, 2017-04)
    BACKGROUND: Craniosynostosis, the premature fusion of one or more cranial sutures, occurs in ∼1 in 2250 births, either in isolation or as part of a syndrome. Mutations in at least 57 genes have been associated with craniosynostosis, but only a minority of these are included in routine laboratory genetic testing. METHODS: We used exome or whole genome sequencing to seek a genetic cause in a cohort of 40 subjects with craniosynostosis, selected by clinical or molecular geneticists as being high-priority cases, and in whom prior clinically driven genetic testing had been negative. RESULTS: We identified likely associated mutations in 15 patients (37.5%), involving 14 different genes. All genes were mutated in single families, except for IL11RA (two families). We classified the other positive diagnoses as follows: commonly mutated craniosynostosis genes with atypical presentation (EFNB1, TWIST1); other core craniosynostosis genes (CDC45, MSX2, ZIC1); genes for which mutations are only rarely associated with craniosynostosis (FBN1, HUWE1, KRAS, STAT3); and known disease genes for which a causal relationship with craniosynostosis is currently unknown (AHDC1, NTRK2). In two further families, likely novel disease genes are currently undergoing functional validation. In 5 of the 15 positive cases, the (previously unanticipated) molecular diagnosis had immediate, actionable consequences for either genetic or medical management (mutations in EFNB1, FBN1, KRAS, NTRK2, STAT3). CONCLUSIONS: This substantial genetic heterogeneity, and the multiple actionable mutations identified, emphasises the benefits of exome/whole genome sequencing to identify causal mutations in craniosynostosis cases for which routine clinical testing has yielded negative results.
  • Item
    Thumbnail Image
    De Novo and Inherited Loss-of-Function Variants in TLK2: Clinical and Genotype-Phenotype Evaluation of a Distinct Neurodevelopmental Disorder.
    Reijnders, MRF ; Miller, KA ; Alvi, M ; Goos, JAC ; Lees, MM ; de Burca, A ; Henderson, A ; Kraus, A ; Mikat, B ; de Vries, BBA ; Isidor, B ; Kerr, B ; Marcelis, C ; Schluth-Bolard, C ; Deshpande, C ; Ruivenkamp, CAL ; Wieczorek, D ; Deciphering Developmental Disorders Study, ; Baralle, D ; Blair, EM ; Engels, H ; Lüdecke, H-J ; Eason, J ; Santen, GWE ; Clayton-Smith, J ; Chandler, K ; Tatton-Brown, K ; Payne, K ; Helbig, K ; Radtke, K ; Nugent, KM ; Cremer, K ; Strom, TM ; Bird, LM ; Sinnema, M ; Bitner-Glindzicz, M ; van Dooren, MF ; Alders, M ; Koopmans, M ; Brick, L ; Kozenko, M ; Harline, ML ; Klaassens, M ; Steinraths, M ; Cooper, NS ; Edery, P ; Yap, P ; Terhal, PA ; van der Spek, PJ ; Lakeman, P ; Taylor, RL ; Littlejohn, RO ; Pfundt, R ; Mercimek-Andrews, S ; Stegmann, APA ; Kant, SG ; McLean, S ; Joss, S ; Swagemakers, SMA ; Douzgou, S ; Wall, SA ; Küry, S ; Calpena, E ; Koelling, N ; McGowan, SJ ; Twigg, SRF ; Mathijssen, IMJ ; Nellaker, C ; Brunner, HG ; Wilkie, AOM (Elsevier BV, 2018-06-07)
    Next-generation sequencing is a powerful tool for the discovery of genes related to neurodevelopmental disorders (NDDs). Here, we report the identification of a distinct syndrome due to de novo or inherited heterozygous mutations in Tousled-like kinase 2 (TLK2) in 38 unrelated individuals and two affected mothers, using whole-exome and whole-genome sequencing technologies, matchmaker databases, and international collaborations. Affected individuals had a consistent phenotype, characterized by mild-borderline neurodevelopmental delay (86%), behavioral disorders (68%), severe gastro-intestinal problems (63%), and facial dysmorphism including blepharophimosis (82%), telecanthus (74%), prominent nasal bridge (68%), broad nasal tip (66%), thin vermilion of the upper lip (62%), and upslanting palpebral fissures (55%). Analysis of cell lines from three affected individuals showed that mutations act through a loss-of-function mechanism in at least two case subjects. Genotype-phenotype analysis and comparison of computationally modeled faces showed that phenotypes of these and other individuals with loss-of-function variants significantly overlapped with phenotypes of individuals with other variant types (missense and C-terminal truncating). This suggests that haploinsufficiency of TLK2 is the most likely underlying disease mechanism, leading to a consistent neurodevelopmental phenotype. This work illustrates the power of international data sharing, by the identification of 40 individuals from 26 different centers in 7 different countries, allowing the identification, clinical delineation, and genotype-phenotype evaluation of a distinct NDD caused by mutations in TLK2.
  • Item
    Thumbnail Image
    A Mutation in Synaptojanin 2 Causes Progressive Hearing Loss in the ENU-Mutagenised Mouse Strain Mozart
    Manji, SSM ; Williams, LH ; Miller, KA ; Ooms, LM ; Bahlo, M ; Mitchell, CA ; Dahl, H-HM ; Krahe, R (PUBLIC LIBRARY SCIENCE, 2011-03-15)
    BACKGROUND: Hearing impairment is the most common sensory impairment in humans, affecting 1:1,000 births. We have identified an ENU generated mouse mutant, Mozart, with recessively inherited, non-syndromic progressive hearing loss caused by a mutation in the synaptojanin 2 (Synj2), a central regulatory enzyme in the phosphoinositide-signaling cascade. METHODOLOGY/PRINCIPAL FINDINGS: The hearing loss in Mozart is caused by a p.Asn538Lys mutation in the catalytic domain of the inositol polyphosphate 5-phosphatase synaptojanin 2. Within the cochlea, Synj2 mRNA expression was detected in the inner and outer hair cells but not in the spiral ganglion. Synj2(N538K) mutant protein showed loss of lipid phosphatase activity, and was unable to degrade phosphoinositide signaling molecules. Mutant Mozart mice (Synj2(N538K/N538K)) exhibited progressive hearing loss and showed signs of hair cell degeneration as early as two weeks of age, with fusion of stereocilia followed by complete loss of hair bundles and ultimately loss of hair cells. No changes in vestibular or neurological function, or other clinical or behavioral manifestations were apparent. CONCLUSIONS/SIGNIFICANCE: Phosphoinositides are membrane associated signaling molecules that regulate many cellular processes including cell death, proliferation, actin polymerization and ion channel activity. These results reveal Synj2 as a critical regulator of hair cell survival that is essential for hair cell maintenance and hearing function.